KI-Zusammenfassung
Wird ausgewertet
Wird ausgewertet
Wir haben 132 Live-Ergebnisse für subsidised insulin glargine lantus dispensing geprüft und auf 3 Optionen eingegrenzt, die sich zuerst am meisten zum Vergleichen eignen.
Die Optionen sind Subsidised Insulin Glargine (Lantus) Dispensing, Lantus, und Lantus Vial.
Quelle: Public Healthcare Institutions
Beschreibung
Provision of Lantus (insulin glargine) through public healthcare pharmacies and outpatient clinics. As an SDL-listed drug, it is available to eligible patients at subsidized rates across polyclinics and restructured hospitals.
Am besten für
Subsidized healthcare seekers, Polyclinic patients, Long Term treatment plans und Government Subsidized medication
Bewertung
Quelle: Sanofi
Beschreibung
Lantus adalah insulin glargine analog kerja panjang yang memberikan pelepasan insulin stabil selama 24 jam. Produk ini merupakan standar emas global untuk terapi insulin basal.
Am besten für
Insulin kerja panjang, Kontrol basal harian, Diabetes tipe 1 dan 2 und Standar global
Bewertung
Quelle: Sanofi-Aventis Singapore Pte. Ltd.
Beschreibung
Insulin glargine 100 units/mL solution for injection in a 10mL vial. This basal insulin offers consistent glucose-lowering effects over a 24-hour period, helping patients maintain stable glycemic control. Use typically involves withdrawal via a separate syringe.
Am besten für
Syringe Based administration, Multi Dose usage, Long Acting blood sugar control und Hospital and clinical use
Bewertung
| Vergleichen | #1Subsidised Insulin Glargine (Lantus) Dispensing | #2Lantus | #3Lantus Vial |
|---|---|---|---|
| Quelle | Public Healthcare Institutions | Sanofi | Sanofi-Aventis Singapore Pte. Ltd. |
| Beschreibung | Provision of Lantus (insulin glargine) through public healthcare pharmacies and outpatient clinics. As an SDL-listed drug, it is available to eligible patients at subsidized rates across polyclinics and restructured hospitals. | Lantus adalah insulin glargine analog kerja panjang yang memberikan pelepasan insulin stabil selama 24 jam. Produk ini merupakan standar emas global untuk terapi insulin basal. | Insulin glargine 100 units/mL solution for injection in a 10mL vial. This basal insulin offers consistent glucose-lowering effects over a 24-hour period, helping patients maintain stable glycemic control. Use typically involves withdrawal via a separate syringe. |
| Am besten für | Subsidized healthcare seekers, Polyclinic patients, Long Term treatment plans und Government Subsidized medication | Insulin kerja panjang, Kontrol basal harian, Diabetes tipe 1 dan 2 und Standar global | Syringe Based administration, Multi Dose usage, Long Acting blood sugar control und Hospital and clinical use |
| Aktion | Subsidised Insulin Glargine (Lantus) Dispensing | Lantus | Lantus Vial |
| Bewertung |
"Subsidised Insulin Glargine (Lantus) Dispensing von Public Healthcare Institutions."
Ich habe dies ausgewählt, weil the most cost-effective option for Singaporean citizens and PRs to access Lantus through government-subsidized healthcare channels.
Hinweis: TopFind stellt Vergleichsinformationen nur zu allgemeinen Recherchezwecken bereit.